Keppel REIT: Prime CBD Franchise and Leasing Momentum Support a Stable BBB Credit

 |   30 Jan 2026  |    5 views

Company Overview

Keppel REIT is a Singapore-listed REIT with a S$9.5bn portfolio value of predominantly Grade-A office assets across Singapore (78%), Australia (18%), South Korea (3%), and Japan (1%). The portfolio is anchored by landmark Singapore CBD assets, including Marina Bay Financial Centre (MBFC), Ocean Financial Centre (OFC), and One Raffles Quay (ORQ). The REIT is sponsored by Keppel Corporation and is rated BBB (S&P).


3Q25 Credit Performance Highlights

Operating performance remains resilient, supporting steady, recurring income and debt service capacity. 3Q25 NPI rose 8.6% YoY to S$161.3mn, driven by stronger contributions from 255 George Street and improved occupancy at 2 Blue Street in Australia. The uplift in recurring income improves cash-flow visibility and underpins Keppel REIT’s ability to service interest and manage upcoming maturities.

Portfolio quality remains a core strength, with prime CBD exposure and sticky tenant demand supporting rents through the cycle. The S$9.5bn AUM is concentrated in Grade-A CBD offices, with portfolio valuations suggesting yields of ~3.15–3.55% for core Singapore assets. Tenant quality is solid, with the top 10 tenants contributing ~30% of rental income, and leasing metrics remain constructive, occupancy improved to 96.3% (3Q25), and WALE is 4.7 years (top 10 tenants 8.9 years). Leasing momentum is evident in ~12% positive rental reversions on new/renewed leases and a 74.9% retention rate, while new Singapore leases were signed at S$12.85 psf pm versus expiring S$11.35–S$12.15, pointing to embedded rental uplift in core CBD locations. The Top Ryde City acquisition (A$393.8mn; entry yield ~6.7%) adds modest diversification via suburban retail and ~1.5% DPU accretive, but it remains small (<5% of AUM), keeping the overall portfolio office-led.

Funding is manageable with moderate leverage and an improving refinancing posture, though coverage is not wide. Leverage stands at 42.2%, providing headroom to the MAS 50% cap, while the cost of debt is ~3.45%, and ~65% of borrowings are fixed-rate. ICR is 2.6x and stress-tested to ~1.9x under a +100bps shock, still workable for an IG REIT, but leaving less margin for prolonged funding-cost pressure. Debt is well laddered, with a 2.7-year weighted average term to maturity, and management is already in active discussions to refinance 2026 MTNs/loans, which is important given the ~S$640mn in 2026 maturities. The sustainability-linked share of borrowings (~82%) also helps broaden lender appetite, though it does not remove repricing risk if rates stay higher for longer.

Looking ahead, the key swing factor is the Singapore office cycle as new CBD supply (e.g., Solitaire on Cecil, Skywaters) enters in 2026–27. If vacancy rises or leasing incentives re-expand, rental reversions and occupancy could normalise from current strong levels, which would matter given Keppel REIT’s office concentration and only moderate coverage buffers. The second watchpoint is the 2026 refinancing execution and the cost of debt repricing. Successful early refinancing would preserve liquidity and reduce event risk, while a higher terminal cost of debt would keep ICR tight and cap spread upside.


Credit view: We maintain a positive stance on Keppel REIT. The credit is supported by a high-quality CBD office franchise, steady operating metrics, and a reasonable liquidity buffer with proactive refinancing intent. While the 2026 maturity hump and potential office-cycle moderation are clear watchpoints, Keppel REIT’s asset quality, tenant stickiness, and leasing momentum should continue to support a stable BBB profile, with spreads likely remaining well supported unless funding costs reprice materially higher or office fundamentals weaken more sharply than expected.


Overview of Keppel REIT’s Outstanding SGD Bonds

Factsheets


Related Articles

Perennial Holdings: Strengthening Healthcare Platform Supports Gradual Credit Improvement

Perennial Holdings is an integrated real estate and healthcare company headquartered in Singapore, with operations spanning China, Singapore, Malaysia, and Ghana.

 |   30 Jan 2026

Aspial Lifestyle: Improved Earnings, but High Leverage and Working-Capital Drag Keep Credit Neutral

Aspial Lifestyle is a consumer lifestyle group operating across Singapore, Malaysia, and Hong Kong, with businesses in jewellery retail, pawnbroking, and secured lending.

 |   30 Jan 2026

Wee Hur Holdings: Asset-backed balance sheet and rising recurring income underpin a conservative credit profile

Wee Hur is a Singapore-based diversified property and construction group with five key pillars: building construction, property development, worker-dormitory operations, Australian PBSA, and fund management/alternative investments.

 |   29 Jan 2026

Disclaimers


These commentaries are intended for general circulation. It does not have regard to the specific investment objectives, financial situation and particular needs of any person who may receive this document. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of the units and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. Investors may wish to seek advice from a financial adviser before investing. In the event that investors choose not to seek advice from a financial adviser, they should consider whether the investment is suitable for them.

The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the "Research") contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries.

Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned.

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com

?>